Herbalife Welcomes Back Michael Levitt to Board of Directors
07 Mar 2024
Executive Change
LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, today announced the appointment of veteran finance executive, Michael Levitt, to its Board of Directors, effective March 1, 2024. Levitt previously served on the Company’s Board as the Lead Director from 2011 to 2014. Kevin Jones, who has served as a director since 2021, will step down from his role on the Board.
Levitt is the Chairman of Irradiant Partners, LP, an investment management firm. He also serves as a member of the firm’s Management and Investment Committees. Prior to the launch of Irradiant Partners, he held various executive and leadership roles at several investment firms, including Kayne Anderson Capital Advisors, LP, Apollo Global Management, LLC, Smith Barney Inc. and Morgan Stanley & Co. Levitt has also served on multiple board of director positions.
“It is with great enthusiasm that I return to Herbalife’s Board of Directors during a transformational time in the Company’s history and look forward to being a part of its future growth,” said Levitt.
The Company and its Board of Directors extend sincere appreciation to Kevin Jones for his board service, valuable perspective, leadership, and commitment to Herbalife.
For more information, visit https://ir.herbalife.com/.
About Herbalife Ltd.
Herbalife (NYSE: HLF) is a premier health and wellness company and community that has been changing people’s lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.